Abbreviations: CID: collision induced dissociation; HexCer: hexosylceramide; LC-MS/MS: liquid chromatography-tandem mass spectrometry; SM: sphingomyelin; SphK1: sphingosine kinase 1; SphK2: sphingosine kinase 2; UVPD: ultraviolet photodissociation.
Introduction
Sphingolipids are a large and diverse family of lipids, heavily enriched in the mammalian brain. They are important regulators of cell signaling and physiology in eukaryotes (1, 2) . The common constituent of sphingolipids is their sphingoid base, which in mammals is predominantly 18-carbon sphingosine that contains a double bond at the C4-5 position (d18:1) ( Figure 1a ). Lipidomic studies often also quantify sphingolipids with the less abundant saturated dihydrosphingosine (d18:0) backbone (2) .
The core diacyl sphingolipid structure is ceramide, which contains a sphingoid base amide-linked to a fattyacyl chain ( Figure 1A) . These fatty-acyl chains vary from 14 to 26 carbons in length, and are generally saturated or mono-unsaturated. Enzymatic addition of different headgroups to the primary hydroxyl of ceramide yields the different classes of sphingolipids, which include sphingomyelin (SM), hexosylceramide (HexCer) and sulfatide.
The length and degree of saturation of the sphingoid base and amide-linked acyl chains of sphingolipids can have a marked impact on their physiological function. For instance, d18:1/16:0 ceramide (C16 ceramide) antagonizes insulin signalling and promotes physiological insulin resistance, whereas its saturated counterpart C16 dihydroceramide (d18:0/16:0 ceramide), which lacks the C4-5 double bond in the sphingoid base, does not (3) . In direct contrast to C16 ceramide, C24 ceramides (d18:1/24:0 and d18:1/24:1) protect against the development of insulin resistance in the liver (4, 5) . The number, position and configuration (cis or trans) of double bonds on both the sphingoid base and fatty-acyl chain greatly affects the membrane packing properties of sphingolipids, which can in turn affect their cellular signaling functions (6, 7) .
Tandem mass spectrometry with conventional collision-induced dissociation (CID) allows for characterisation of lipid headgroups, acyl chain length, and number of carbon-carbon double bonds, but provides no information on the position of the double bonds. UVPD-MS/MS is an emerging approach for structural characterisation of lipids in which high-energy excitation through absorption of 193 nm UV photons causes direct dissociation, yielding product ion and structural data that is not observed with conventional CID (8) (9) (10) (11) (12) . Importantly, 193 nm UV excitation results in characteristic dissociation of bonds adjacent to carbon-carbon double bonds in lipid acyl chains, allowing the location of double bonds within the acyl chains to be determined.
Phosphorylation of sphingosine and other sphingoid bases by sphingosine kinases 1 and 2 (SphK1 and 2) forms the lipid signalling molecule sphingosine 1-phosphate (S1P) and related sphingoid base phosphates (13, 14) . S1P executes a wide array of cell signalling roles both through a family of five G-protein coupled receptors that are specific to S1P (13, 15) , and through specific intracellular S1P binding targets such as histone deacetylases (16) . In addition to forming the signalling molecule S1P, sphingosine phosphorylation is an essential and evolutionarily-conserved step in the catabolism of all sphingolipids. This proceeds through irreversible degradation of S1P by S1P lyase, forming hexadecenal and ethanolamine phosphate ( Figure 1B) (1, 2) .
As the only pathway for complete catabolism of sphingolipids, sphingosine kinases and S1P lyase are key regulators of sphingolipid homeostasis (17) . In mice, loss of S1P lyase is lethal within a few weeks of weaning, attributed to a range of gross developmental defects (18, 19) and pronounced deregulation of lipid levels in multiple organs (20) . The absence of S1P lyase causes increased sphingolipid biosynthesis via the salvage pathway, which is associated with reduced de novo sphingolipid biosynthesis, thus causing widespread disruption to lipid metabolism (21) . Loss of both SphK1 and SphK2 is also lethal, however the mice die with defects in vasculogenesis and neurogenesis attributed to loss of S1P signalling functions (22) . Mice lacking either SphK1 or SphK2 exhibit no obvious phenotypic abnormalities.
We have previously reported loss of S1P and SphK2 activity early in the pathogenesis of Alzheimer's disease (23) , and recently demonstrated that loss of SphK2 sensitizes to hippocampal atrophy and myelin loss in a mouse model of Alzheimer's disease (24). We have also shown heightened anxiety in mice lacking SphK2 (25) . SphK2 catalyses the majority of S1P synthesis in the brain (25) , and an important role for SphK2 in protection against brain atrophy following cerebral ischaemia has been established (26) . Here, we report pronounced and selective accumulation of sphingolipids containing a second double bond in the sphingoid base, termed sphingadienes, in the hippocampus of SphK2 knockout (SphK2 -/-) mice. Employing the emerging technique of UVPD-MS/MS, the double bonds were unambiguously assigned to positions C4-C5 and C14-C15 in the sphingoid base backbone of these lipids. In metabolic tracing experiments, we show that these sphingadiene-containing lipids are catabolized more slowly than the more abundant sphingosine-based sphingolipids, and therefore propose that sphingadiene lipids accumulate in brains of SphK2 -/mice due to poor degradation via the sphingosine kinase-S1P lyase pathway.
Materials and Methods

Lipid standards
All lipids, with the exception of 17:0/17:0/17:0 triacylglycerol (TAG) (Cayman Chemical, USA), were purchased from Avanti Polar Lipids (distributed by Sigma Aldrich, Castle Hill, NSW, Australia). All lipid extractions were spiked with an internal standard mixture comprising of 0.2 nmole of d17:1 Sph (860640) and S1P (860641), and 1 nmole of each of the following: d18:1/12:0 SM (860583) 
Mouse tissue samples
Mice lacking functional SphK1 (SphK1 -/-) or SphK2 (SphK2 -/-) were derived by breeding heterozygous parents (i.e. SphK1 +/-´ SphK1 +/or SphK2 +/-´ SphK2 +/-), allowing us to compare SphK1 -/and SphK2 -/mice to their wild-type (WT) littermates (i.e. SphK1 +/+ or SphK2 +/+ ). Genotyping was performed as described previously (22) . Mice were housed in ventilated cages with enrichment consisting of nesting material and a plastic dome, and were given access to food and water ad libitum. For untargeted mass spectrometry analysis, we used groups of 6 male SphK2 -/and WT mice at 8 months of age, or 6 (3 male and 3 female) SphK1 -/and 8 (3 male and 5 female) WT mice at 6 months of age. A separate cohort of male SphK2 -/-(n = 9) and WT (n = 11) mice, aged 6 months, were used for targeted lipidomic analysis of the 
Lipid extraction
Lipids were extracted from dissected hippocampus, liver tissue and cell extracts tissue using a two-phase procedure with methyl-tert-butyl ether (MTBE)/methanol/water (10:3:2.5, v/v/v) (28, 29) . Hippocampus (10-20 mg) and liver tissue (5-10 mg) were pulverised over dry ice, and transferred to 10 mL glass tubes containing 1.7 mL of MTBE, 500 µl of methanol, and 0.01% butylated hydroxytoluene, spiked with the internal standard mixture. Samples were sonicated in an ice-cold sonicating water bath (Unisonics Australia) for 3 x 30 min. Phase separation was induced by addition of 417 µL of mass spectrometry-grade water, followed by vortexing and centrifugation at 1000 × g for 10 min. The upper organic phase was collected in 5 mL glass tubes. The lower phase was re-extracted by adding 1 mL MTBE, 300 μL methanol, and 250 μL water. The organic phases were combined and dried under vacuum in a Savant SC210 SpeedVac (ThermoFisher Scientific), reconstituted in 300 μL methanol and stored at −20 °C for subsequent analysis.
Lipid Quantification by LC-MS/MS
Untargeted Lipidomics: Lipid extracts from hippocampus tissue were analysed on a Q-Exactive HF-X mass spectrometer with heated electrospray ionization (HESI) probe and Vanquish UHPLC system (Thermo Fisher, Breman, Germany). Extracts were resolved on a 2.1 × 100 mm Waters Acquity C18 UPLC column 
Lipid characterisation by 193 nm UVPD-MS/MS
193 nm UVPD-MS/MS was implemented on a custom modified Q-Exactive Plus Orbitrap mass spectrometer (Thermo Fisher), using the output from a Coherent ExciStar 500 XS ArF excimer laser (Santa Clara, CA, USA), as previously described (12) . ions formed from 193-nm UVPD fragmentation, as described previously (12) .
Western blotting
Cells were lysed in RIPA buffer (20 mM 
Statistical analysis
For both untargeted and targeted lipidomic analysis, levels of each lipid were compared between SphK2 -/and WT mice (or SphK1 -/and WT) using a two-tailed unpaired t-test. Values were first log-transformed (natural log) to achieve a normal distribution for t-tests. P-values were adjusted for multiple comparisons using the false discovery rate approach of Benjamini, Krieger, and Yekutieli, with Q < 0.1 and 0.05 
Results
Accumulation of sphingadiene lipids in the hippocampus of SphK2 deficient mice
Untargeted lipidomic (LC-MS/MS) analysis of hippocampus tissue from SphK1 -/and SphK2 -/mice, along with WT control littermates for each, identified phospholipids (phosphatidylcholine, PC;
phosphatidylethanolamine, PE; phosphatidylserine, PS), sphingolipids (ceramide, Cer; sulfatide, ST;
hexosylceramide, HexCer; sphingomyelin, SM), and neutral (diacylglycerol, DAG; and triacylglycerol, TAG) lipid species. Lipids identified using LipidSearch software were manually verified for peak shape and correct product ions, resulting in a total of 357 confirmed lipids in SphK2 -/and 363 in SphK1 -/mice.
After adjusting for false discovery rate, a total of thirteen lipids were significantly increased in SphK2 -/compared to WT mice ( Figure 2A and Table 1 ). In contrast, no lipids differed significantly in abundance between SphK1 -/mice and their WT littermates ( Figure 2B ). All thirteen lipids whose levels were significantly increased in SphK2 -/mice were sphingolipids containing a sphingadiene ( Table 3 ). In contrast, the total level of d18:1 ceramides increased by a more modest 1.3-fold (P = 0.021) in SphK2 -/hippocampus samples, and there was no significant difference in total levels of d18:1 SM, HexCer, and sulfatide ( Figure   3A -D). Sphingosine and sphingadiene were 2-and 5-fold higher, respectively, in the hippocampus of SphK2 -/mice ( Figure 3E , both P < 0.001); whilst S1P and sphingadiene 1-phosphate were 3.5-(P = 0.0002) and 2-fold (P = 0.007) lower, respectively ( Figure 3F ). The 72% reduction in d18:1 S1P in SphK2 -/mouse brains is in agreement with prior data showing that SphK2 is responsible for the majority of S1P synthesis in the brain (25) .
To determine if SphK2 -/mice accumulate sphingadiene lipids in another tissue that expresses relatively high levels of SphK2 (31), we also quantified sphingolipids in liver. Ceramides with a d18:1 sphingoid base were 5-fold higher (P = 0.007), whilst those with a d18:2 base were 8-fold higher (P = 0.022) in SphK2 -/compared to WT mouse livers ( Figure 3G ). SM and HexCer with d18:1 sphingoid bases, as well as d18:2 SM species, did not differ significantly between the two genotypes, whereas d18:2 HexCer was 2.5-fold higher (P = 0.024) in the SphK2 -/livers ( Figure 3H -I and Supplementary Table 4 ). Sphingosine and sphingadiene levels were 3-fold (P = 0.011) and 5-fold (P = 0.0005) higher ( Figure 3J ), whilst S1P was 2fold lower (P = 0.018), in SphK2 -/liver tissue ( Figure 3K ). Sphingadiene 1-phosphate was not significantly altered in SphK2 -/liver tissue. Therefore, as observed in hippocampus, there was a preferential increase of d18:2 relative to d18:1 sphingolipids in livers of SphK2-deficient mice.
UVPD-MS/MS assigns double bonds to the C4 and C14 position of sphingadiene
To pinpoint the position of the double bonds in the major brain sphingadiene lipids, we employed 193 nm 
Both SphK1 and SphK2 exhibit similar affinity for sphingosine and sphinga-4,14-diene
SphK2 is quantitatively more important for S1P synthesis in the brain than SphK1 ( Figure 3F ) (25) , and demonstrates broader substrate specificity, as it is able to catalyse the phosphorylation of phytosphingosine and the sphingoid base analog Fingolimod, as well as sphingosine and dihydrosphingosine (31, 32) . As sphingosine kinases catalyse an essential step in the catabolism of all sphingolipids, we assessed whether accumulation of sphingadiene-containing lipids may be attributed to poor affinity of SphK1 for sphingadiene as a substrate. This would result in selective accumulation of sphingadiene lipids in the absence of SphK2. We therefore compared phosphorylation of sphingosine and sphinga-4,14-diene over time in brain lysates of SphK1 -/or SphK2 -/mice. Sphingosine kinase activity in these mice is wholly dependent on SphK2 or SphK1, respectively. Deuterated sphingosine (D7-sphingosine) was used to avoid interference from endogenous sphingosine and S1P present in the brain lysates used as the source of enzyme for the reactions. No deuterated standard was available for sphingadiene, and we therefore used the unlabelled standard. Both SphK1 (SphK2 -/brain extracts) and SphK2 (i.e. SphK1 -/brain extracts) phosphorylated sphingadiene with similar efficiency to sphingosine ( Figure 5A-D) . The in vitro phosphorylation rate was much lower in SphK1 -/than SphK2 -/brain extracts. This is in agreement with a recent publication reporting that SphK1 is much more efficient than SphK2 in the in vitro sphingosine kinase activity assay, whereas SphK2 deficiency has a much greater effect than SphK1 deficiency on neuronal S1P levels (33) .
We also investigated the affinity and maximal reaction rate of recombinant human SphK1 and SphK2 for sphingosine and sphinga-4,14-diene. The Michaelis constant (Km) and maximum reaction rate (Vmax) for sphingosine were 6.2 μM and 1832 pmol/min/µg for SphK1; and 4.6 μM and 36.98 pmol/min/µg for SphK2
( Figure 5E and F). These Km values correspond well with previously reported values for SphK1 (5-17 μM) and SphK2 (3-5 μM) (31, (34) (35) (36) . The Km and Vmax values for sphinga-4,14-diene were 3.2 μM and 1469 pmol/min/µg for SphK1; and 8.5 μM and 69.10 pmol/min/µg for SphK2 ( Figure 5E and F) . Therefore, the accumulation of sphingadiene-containing lipids in the absence of SphK2 cannot be explained by poor affinity of SphK1 for sphingadiene.
Sphingadiene (d18:2) ceramides are metabolised more slowly than d18:1 ceramides
Given that sphingadiene and sphingosine are phosphorylated at equivalent rates by SphK1 and SphK2, we tested if the accumulation of sphingadiene-containing lipids in SphK2 -/brains could be attributed to intrinsically slower turnover of these lipids in comparison to their more abundant d18:1 counterparts. This could cause selective accumulation of sphingadiene-containing lipids in SphK2 -/brains, as the rate of catabolism for all sphingolipids is predicted to be slower in the absence of SphK2. As the majority of brain lipids are synthesized by oligodendrocytes (37, 38) , we performed a pulse-chase experiment with the oligodendrocyte cell line MO13.3, first loading cells with deuterated (D7) sphingosine for 2 h, then following the levels of D7-labelled sphingolipids over time after removal of the D7-sphingosine tracer. To test the role of SphK2 in metabolism of labelled sphingolipids, we generated cells stably expressing shRNA against SphK2 (shSphK2) and non-silencing shRNA control cells (shCtrl). Effective silencing of SphK2 with two distinct shRNA sequences (shSphK2-A and shSphK2-B) was confirmed by western blot ( Figure   6A ).
After loading with D7-sphingosine, we detected quantifiable amounts of D7-labelled sphingadiene-based ceramide, HexCer, and SM. Over 70% were lipids containing a C16:0 N-acyl chain, and we have therefore shown levels of these C16:0 lipids over time ( Figure 6B Figure 6H) , presumably as the sphingosine was converted to other sphingolipids. D7sphingadiene was not detected, suggesting that the D14 desaturase that produces sphinga-4,14-diene acts on ceramide, rather than sphingosine, as its substrate. As expected, D7-S1P was higher in shCtrl compared to shSphK2-A cells ( Figure 6I Figure 6N-O) . Overall, these results demonstrate that d18:1 ceramides are more rapidly metabolised than d18:2 ceramides.
Discussion
Sphingosine kinases fulfill dual biochemical functions in mammalian biology. Firstly, they produce the physiologically-essential signalling molecule S1P, which signals both through a family of five G-protein coupled receptors, and through intracellular binding targets. Secondly, they catalyse the penultimate step in the catabolism of sphingolipids, as phosphorylation of sphingoid bases is necessary for their degradation by S1P lyase (1, 13, 15) . Here, we establish that sphingolipids with a sphingadiene long chain base accumulate in the hippocampus of SphK2 -/but not SphK1 -/mice. Using the emerging fragmentation method of UVPD-MS/MS, we localized the double bonds to the C4-C5 and C14-C15 positions of the sphingoid base chain, allowing us to test the rate of phosphorylation of this sphingoid base by SphK1 and SphK2 in vitro. There was no intrinsic difference in the capacity for either SphK1 or SphK2 to phosphorylate sphinga-4,14-diene compared to sphingosine. Instead, we show that d18:1 ceramide levels decline over a 2 h time-course in cultured cells, whereas d18:2 ceramide levels do not. Whereas d18:1
HexCer levels were relatively unchanged over the 2 h time course, d18:2 HexCer levels increased. These results suggest that ceramides with a sphinga-4,14-diene backbone are less efficiently catabolized than the more common sphingosine-based lipids. As SphK2 catalyses the bulk of S1P synthesis in the brain (24, 25, 33), the less efficient catabolism of sphingadiene lipids combined with SphK2 deficiency results in abnormal accumulation of these lipids.
Our findings are strongly supported by a very recent publication showing that, compared to S1P, sphinga-4,14-diene 1-phosphate is less efficiently catabolized by S1P lyase in vitro (using cell extracts) (39) . Our data extends this work by demonstrating that sphingadiene-containing lipids are more slowly catabolized than sphingosine-containing lipids in living cells. Similarly, S1P lyase mutants in the fly Drosophila melanogaster accumulate sphinga-4,6-diene (54) , which is speculated to contribute to muscle degeneration (40) . In agreement with our data, Jojima et al (39) also found that both SphK1 and SphK2 catalyse sphingadiene phosphorylation as efficiently as sphingosine. We note that in their study, Jojima et al did not lipooligosaccharides (9, 11) , gangliosides (10) and sphingolipids (12) . However, this is the first report employing UVPD-MS/MS in combination with genetic models to answer specific biological questions concerning lipid metabolism and function. UVPD-MS/MS does not require any derivatisation, modification, or chromatographic separation to resolve sites of unsaturation, making this a powerful technique that can be readily incorporated into lipidomic workflows. An alternative MS/MS approach for double bond assignment is ozonolysis, which coverts alkene bonds to ozonoids that fragment into product ions pairs diagnostic of double bond position (41, 42) . However, an ozone source may create unwanted hazards, the ionisation efficiency of ozonolysis is reportedly reduced in positive ion mode, and the high capillary voltage reduces sensitivity (43) . Comprehensive structural characterization of lipids can also be performed using electron induced dissociation (EID) in combination with differential ion mobility spectrometry [also referred to as electron-impact excitation of ions from organics (EIEIO)] (44, 45) . Our assignment of the second double bond in murine brain sphingadiene to the C14-C15 position is in agreement with three publications from the late 1960s in which chemical derivatisation techniques coupled to thin-layer or gas chromatography were used to determine double bond positions in d18:2 SM species of human plasma and aorta samples (46) (47) (48) . Despite this, the levels and functional significance of sphingadiene-containing lipids has been very sparsely investigated relative to the sphingoid bases sphingosine and sphinganine (dihydrosphingosine), and they are often not included in routine lipidomic analyses. It was very recently shown that d18:2 is the second most abundant sphingoid base in human plasma (49) , and that levels of sphinga-4,14-diene in mice are highest in kidney, followed by brain, lung, and then colon (39) . Sphingadienes with double bonds in the C4-C5 and C8-C9 positions of the sphingoid base chain are common in plants and fungi such as soybean, corn, wheat and yeast (50, 51) . Naturally occurring sphingadienes inhibit both chemically-and genetically-induced colon cancer development in mice (51) (52) (53) , associated with disrupted Akt membrane translocation and signaling (53) , and reduced Wnt transcriptional activity (52) . Sphingadienes have also been shown to suppress the growth of neuroblastoma xenograft tumors (54) .
Introduction of the C4-C5 trans double bond into ceramide is catalysed by Δ4-dihydroceramide desaturase (DEGS1) (55) . Two research teams very recently identified FADS3 as the desaturase catalyzing the addition of the C14-C15 double bond in the long chain base (39, 49) . Jojima et al (39) presented evidence indicating that the second double bond in the sphingadiene base is introduced into ceramide, not sphingosine. Our data also suggested that desaturation at the C14-C15 bond occurs in ceramide, not sphingosine, as D7sphingadiene was below the limit of detection in cell culture, despite abundant levels of D7-sphingosine and clearly detectible D7-d18:2 sphingolipids. In contrast, Karsai et al (49) showed that FADS3 can directly desaturate sphingosine in vitro, however inhibiting ceramide synthesis with Fumonisin B1 greatly reduced sphingadiene formation in living cells. Mice lacking FADS3 have reduced brain docosahexaenoic acid levels but were reported to display no major phenotypic abnormalities (56) . However the International Mouse Phenotyping Consortium (https://www.mousephenotype.org) (57) report impaired auditory response, decreased circulating phosphates, and increased serum albumin in FADS3 knockout mice.
The C14-C15 double bond in sphinga-4,14-diene is a cis bond (14) , which introduces a kink in the acyl chain and is thereby expected to decrease the packing density of the lipid bilayer. Accordingly, Jojima et al (39) showed that a lower proportion of d18:2 HexCer localizes to detergent-resistant membrane domains compared to d18:1 HexCer. The brain is enriched with sphingolipids, so an increased proportion of d18:2(4,14) sphingolipids may have important consequences for neuronal lipid domains and myelin integrity. We have reported that SphK2 deficiency synergises with an amyloid-producing transgene to create severe myelin deficits (24). It is possible that myelin structure and function is destabilized by an increased abundance of sphingadiene lipids in SphK2 -/mice, and this will be investigated in future studies.
In conclusion, we have identified significant accumulation of sphingolipids containing a sphingadiene base in the hippocampus of mice lacking functional SphK2 and have employed the emerging technique of UVPD-MS/MS to assign double bond positions to the C4-C5 and C14-C15 positions. To the best of our knowledge, this is the first study to apply UVPD-MS/MS towards an improved understanding of metabolic pathways and enzyme function. The biology of sphingadiene-containing lipids has not been elucidated, and these lipids have not commonly been assayed in targeted lipidomic analyses. Sphingosine kinases remain targets of interest for cancer therapy, and inhibitors of both SphK1 and SphK2 have been investigated in clinical trials. Our findings demonstrate the importance of analyzing and better understanding the functional significance of sphingadiene lipids, particularly given that circulating levels of these lipids were reported as significantly higher in females (49) , and knockout of SphK2, or Bax and Bak (58) , has now been shown to alter the balance between sphingadiene-and sphingosine-containing lipids. which can be recycled back to ceramide in the salvage pathway or phosphorylated by SphK1 or SphK2, forming S1P. S1P can also be reutilised for sphingolipid synthesis in the salvage pathway or broken down in the endoplasmic reticulum by S1P lyase (SPL). 
